DaVita Inc.
NYSEDaVita reported Q2 earnings on August 4 and the market's reaction has been swift — the stock dropped 2.4% on the day and is now down nearly 5% on the week to $227.99, reversing most of the pre-earnings momentum that carried shares to $240 just days ago. The post-earnings move has pushed the stock below most analyst price targets for the first time in weeks. The mean target now sits…
Snapshot as of 6 Aug 2026
DaVita reported Q2 earnings on August 4 and the market's reaction has been swift — the stock dropped 2.4% on the day and is now down nearly 5% on the week to $227.99, reversing most of the pre-earnings momentum that…
DaVita reports Q2 results on August 4 with short sellers pulling back and analysts chasing the stock higher — yet the price has already moved well past most targets on the Street. The short interest picture has shifted…
DaVita enters its June 4 earnings report with a sharply divided ownership story: Berkshire Hathaway trimmed its stake in May, CFO Joel Ackerman sold nearly $10 million in stock, and yet the shares are still up 30% over…
DaVita enters the week after one of its best earnings prints in years — and the market's reaction has split the tape between a jubilant price move and a cluster of insider exits at the new highs. The catalyst was…
DaVita enters the week after earnings on a completely different footing than it started — a Deutsche Bank upgrade to Buy with a $220 target has reset the debate on a stock that most of the Street had treated as dead…
DaVita enters its May 5 Q1 2026 earnings report with a notable and consistent insider-selling signal — every transaction logged over the 90-day window has been a sale, not a buy. On March 13, multiple senior executives…
DVA heads into its May 1 Q1 results carrying one of the more charged setups in health care services — a meaningful short position, a Berkshire anchor, and the shadow of February's explosive earnings gap. Short sellers…
DaVita Inc. reports Q1 results after the bell on May 1 carrying a specific burden: the last time it posted earnings, shorts fled the stock and the price ripped more than 23% in a single session — and the Street hasn't…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DVA — free to start on ORTEX.
Sign up for free →Open DVA on ORTEX